Cat.#: 28145 |
Product Name: Anti-PDL1 (Durvalumab) Monoclonal Antibody |
Synonyms: PD-L1;CD274;B7-H1;PDCD1L1;PDCD1LG1 |
Description: Anti-PDL1 (durvalumab ) Monoclonal Antibody |
Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
Applications: Flow Cyt |
Recommended Dilutions: Flow Cyt 1:100 |
Host Species: Humanized |
Isotype: IgG1(K97R, L117F, L118E, P214S) |
Purification: Purified from cell culture supernatant by affinity chromatography |
Species Reactivity: Human PDL1 |
Constituents: Lyophilized from sterile PBS, pH 7.4. 5 % – 8% trehalose is added as protectants before lyophilization. |
Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). |
 Figure 1. Flow cytometry analysis with 1 µg/mL Anti-PDL1(durvalumab biosimilar) mAb (28145) on Expi293 cells transfected with Human PDL1 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram). |  Figure 2. ELISA plate pre-coated by 2 µg/ml (100 µl/well) Human PDL1, mFc-His tagged protein 11151 can bind Anti-PDL1 (durvalumab biosimilar) Neutralizing antibody (28145) in a linear range of 0.61-9.77 ng/ml. |
|